These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17457048)

  • 1. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.
    Takaoka M; Kim SH; Okawa T; Michaylira CZ; Stairs DB; Johnstone CN; Andl CD; Rhoades B; Lee JJ; Klein-Szanto AJ; El-Deiry WS; Nakagawa H
    Cancer Biol Ther; 2007 Apr; 6(4):534-40. PubMed ID: 17457048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.
    Silha JV; Sheppard PC; Mishra S; Gui Y; Schwartz J; Dodd JG; Murphy LJ
    Endocrinology; 2006 May; 147(5):2112-21. PubMed ID: 16469805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I.
    Takaoka M; Smith CE; Mashiba MK; Okawa T; Andl CD; El-Deiry WS; Nakagawa H
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G404-16. PubMed ID: 16210470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice.
    Silha JV; Gui Y; Mishra S; Leckstrom A; Cohen P; Murphy LJ
    Endocrinology; 2005 Mar; 146(3):1523-31. PubMed ID: 15550509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
    Kim HS; Ingermann AR; Tsubaki J; Twigg SM; Walker GE; Oh Y
    Cancer Res; 2004 Mar; 64(6):2229-37. PubMed ID: 15026367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3.
    Takaoka M; Harada H; Andl CD; Oyama K; Naomoto Y; Dempsey KL; Klein-Szanto AJ; El-Deiry WS; Grimberg A; Nakagawa H
    Cancer Res; 2004 Nov; 64(21):7711-23. PubMed ID: 15520175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells.
    Hong J; Zhang G; Dong F; Rechler MM
    J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
    Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
    Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer.
    Hochscheid R; Jaques G; Wegmann B
    J Endocrinol; 2000 Sep; 166(3):553-63. PubMed ID: 10974650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.
    Shukla S; Mishra A; Fu P; MacLennan GT; Resnick MI; Gupta S
    FASEB J; 2005 Dec; 19(14):2042-4. PubMed ID: 16230333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
    Ye P; Qu CF; Hu XL
    Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis.
    Liu B; Lee KW; Anzo M; Zhang B; Zi X; Tao Y; Shiry L; Pollak M; Lin S; Cohen P
    Oncogene; 2007 Mar; 26(12):1811-9. PubMed ID: 16983336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.
    Oh SH; Lee OH; Schroeder CP; Oh YW; Ke S; Cha HJ; Park RW; Onn A; Herbst RS; Li C; Lee HY
    Mol Cancer Ther; 2006 Nov; 5(11):2685-95. PubMed ID: 17121915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
    Devi GR; Graham DL; Oh Y; Rosenfeld RG
    Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.
    Dubaquié Y; Mortensen DL; Intintoli A; Hogue DA; Nakamura G; Rancatore P; Lester P; Sadick MD; Filvaroff E; Fielder PJ; Lowman HB
    Endocrinology; 2001 Jan; 142(1):165-73. PubMed ID: 11145579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
    Robinson SA; Rosenzweig SA
    Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner.
    Shahjee H; Bhattacharyya N; Zappala G; Wiench M; Prakash S; Rechler MM
    Growth Horm IGF Res; 2008 Jun; 18(3):188-97. PubMed ID: 17959403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.